OOIR: Observatory of International Research

Papers

(The H4-Index of Eye is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Infectious keratitis: an update on epidemiology, causative microorganisms, risk factors, and antimicrobial resistance	215
Ocular benzalkonium chloride exposure: problems and solutions	97
Angiopoietin/Tie2 signalling and its role in retinal and choroidal vascular diseases: a review of preclinical data	97
Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD	72
Deep learning-based automated detection for diabetic retinopathy and diabetic macular oedema in retinal fundus photographs	62
Conventional glaucoma implants and the new MIGS devices: a comprehensive review of current options and future directions	59
Review of retinal cameras for global coverage of diabetic retinopathy screening	57
Ophthalmic manifestations of monkeypox virus	56
Ocular coloboma—a comprehensive review for the clinician	56
Review of gene therapies for age-related macular degeneration	54
Optical coherence tomography in the 2020s—outside the eye clinic	52
Teprotumumab for the treatment of chronic thyroid eye disease	51
Acute macular neuroretinopathy following COVID-19 vaccination	47
Optical coherence tomography (OCT) in neuro-ophthalmology	47
Recently updated global diabetic retinopathy screening guidelines: commonalities, differences, and future possibilities	46
Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial	45
Drusen and pachydrusen: the definition, pathogenesis, and clinical significance	44
The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study – 6 month results	44
Dupilumab-associated ocular surface disease: presentation, management and long-term sequelae	43
Optical coherence tomography as retinal imaging biomarker of neuroinflammation/neurodegeneration in systemic disorders in adults and children	42
Retinal vein occlusion (RVO) guideline: executive summary	42
The Royal College of Ophthalmologists recommendations on monitoring for hydroxychloroquine and chloroquine users in the United Kingdom (2020 revision): executive summary	41
Adaptive optics: principles and applications in ophthalmology	41
Comparative analysis of large language models in the Royal College of Ophthalmologists fellowship exams	40
A review of acquired blepharoptosis: prevalence, diagnosis, and current treatment options	40

Repeatability of total Keratometry and standard Keratometry by the IOLMaster 700 and comparison to total corneal astigmatism by Scheimpflug imaging	40
Myopia prediction: a systematic review	39
Biomechanical properties of retina and choroid: a comprehensive review of techniques and translational relevance	38
The effect of home education on myopia progression in children during the COVID-19 pandemic	38
Complement cascade inhibition in geographic atrophy: a review	38
Natural history of patients with Leber hereditary optic neuropathy—results from the REALITY study	37
Comparison of GPT-3.5, GPT-4, and human user performance on a practice ophthalmology written examination	37
Ocular surface squamous neoplasia: management and outcomes	36
Precise, simplified diagnostic criteria and optimised management of initial-onset Vogt–Koyanagi–Harada disease: an updated review	36
Teprotumumab for non-inflammatory thyroid eye disease (TED): evidence for increased IGF-1R expression	36
Neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disorder-optic neuritis: a comprehensive review of diagnosis and treatment	36